(NASDAQ:ARVN), who have seen the share price tank a massive 86% over a three year period. That might cause some serious doubts about the merits of the initial decision to buy the stock, to put it ...

Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.

Celcuity shares jump as gedatolisib shows strong efficacy in HR+/HER2- breast cancer Phase 3 trial, with FDA filing expected ...

Results from the POLARGO trial “reinforce the benefit of adding polatuzumab to chemoimmunotherapy,” said Matthew Matasar, MD.

Amarin Corporation AMRN reported a loss of 3 cents per share for the second quarter of 2025, which was significantly narrower ...

United Therapeutics UTHR reported second-quarter 2025 earnings of $6.41 per share, which missed the Zacks Consensus Estimate ...

Andrew Murstein, President and Chief Operating Officer of Medallion Financial, commented, "We are pleased with the strong results we delivered in the second quarter of 2025, with a 56% increase in net ...